nodes	percent_of_prediction	percent_of_DWPC	metapath
Telmisartan—ABCC2—epilepsy syndrome	0.128	0.339	CbGaD
Telmisartan—ABCG2—epilepsy syndrome	0.113	0.3	CbGaD
Telmisartan—CYP2C19—epilepsy syndrome	0.089	0.236	CbGaD
Telmisartan—ABCC2—Levetiracetam—epilepsy syndrome	0.0523	0.135	CbGbCtD
Telmisartan—ABCB1—epilepsy syndrome	0.0471	0.125	CbGaD
Telmisartan—ABCC2—Carbamazepine—epilepsy syndrome	0.03	0.0774	CbGbCtD
Telmisartan—ABCC2—Phenytoin—epilepsy syndrome	0.0269	0.0694	CbGbCtD
Telmisartan—ABCC2—Phenobarbital—epilepsy syndrome	0.024	0.0619	CbGbCtD
Telmisartan—CYP2C19—Oxcarbazepine—epilepsy syndrome	0.0193	0.0498	CbGbCtD
Telmisartan—CYP2C19—Felbamate—epilepsy syndrome	0.018	0.0463	CbGbCtD
Telmisartan—CYP2C19—Trimethadione—epilepsy syndrome	0.018	0.0463	CbGbCtD
Telmisartan—ABCB1—Levetiracetam—epilepsy syndrome	0.017	0.0439	CbGbCtD
Telmisartan—CYP2C19—Fosphenytoin—epilepsy syndrome	0.0169	0.0435	CbGbCtD
Telmisartan—CYP2C19—Clobazam—epilepsy syndrome	0.0146	0.0378	CbGbCtD
Telmisartan—CYP2C19—Carbamazepine—epilepsy syndrome	0.0121	0.0313	CbGbCtD
Telmisartan—ABCB1—Clobazam—epilepsy syndrome	0.0118	0.0305	CbGbCtD
Telmisartan—ABCB1—Lamotrigine—epilepsy syndrome	0.0114	0.0293	CbGbCtD
Telmisartan—CYP2C19—Primidone—epilepsy syndrome	0.0113	0.0292	CbGbCtD
Telmisartan—CYP2C19—Phenytoin—epilepsy syndrome	0.0109	0.0281	CbGbCtD
Telmisartan—CYP2C19—Propofol—epilepsy syndrome	0.0102	0.0262	CbGbCtD
Telmisartan—ABCB1—Carbamazepine—epilepsy syndrome	0.00979	0.0252	CbGbCtD
Telmisartan—CYP2C19—Phenobarbital—epilepsy syndrome	0.0097	0.025	CbGbCtD
Telmisartan—CYP2C19—Diazepam—epilepsy syndrome	0.0092	0.0237	CbGbCtD
Telmisartan—CYP2C19—Zonisamide—epilepsy syndrome	0.00898	0.0231	CbGbCtD
Telmisartan—ABCB1—Phenytoin—epilepsy syndrome	0.00878	0.0226	CbGbCtD
Telmisartan—ABCB1—Phenobarbital—epilepsy syndrome	0.00783	0.0202	CbGbCtD
Telmisartan—ABCB1—Midazolam—epilepsy syndrome	0.00772	0.0199	CbGbCtD
Telmisartan—ABCB1—Diazepam—epilepsy syndrome	0.00742	0.0191	CbGbCtD
Telmisartan—CYP2C19—Valproic Acid—epilepsy syndrome	0.00725	0.0187	CbGbCtD
Telmisartan—CYP2C19—Topiramate—epilepsy syndrome	0.00654	0.0169	CbGbCtD
Telmisartan—Olmesartan—ABCC2—epilepsy syndrome	0.000516	0.497	CrCbGaD
Telmisartan—PPARG—forelimb—epilepsy syndrome	0.000316	0.266	CbGeAlD
Telmisartan—Losartan—CYP2C19—epilepsy syndrome	0.00018	0.173	CrCbGaD
Telmisartan—Candesartan—ABCB1—epilepsy syndrome	0.000148	0.142	CrCbGaD
Telmisartan—Losartan—ALB—epilepsy syndrome	9.97e-05	0.096	CrCbGaD
Telmisartan—Losartan—ABCB1—epilepsy syndrome	9.51e-05	0.0916	CrCbGaD
Telmisartan—AGTR1—forebrain—epilepsy syndrome	8.72e-05	0.0733	CbGeAlD
Telmisartan—PPARG—forebrain—epilepsy syndrome	7.17e-05	0.0603	CbGeAlD
Telmisartan—AGTR1—medulla oblongata—epilepsy syndrome	6.3e-05	0.0529	CbGeAlD
Telmisartan—AGTR1—head—epilepsy syndrome	4.99e-05	0.042	CbGeAlD
Telmisartan—AGTR1—nervous system—epilepsy syndrome	4.73e-05	0.0398	CbGeAlD
Telmisartan—AGTR1—central nervous system—epilepsy syndrome	4.56e-05	0.0383	CbGeAlD
Telmisartan—ABCG2—telencephalon—epilepsy syndrome	4.23e-05	0.0355	CbGeAlD
Telmisartan—PPARG—head—epilepsy syndrome	4.11e-05	0.0345	CbGeAlD
Telmisartan—Dermatitis—Diazepam—epilepsy syndrome	3.91e-05	0.000239	CcSEcCtD
Telmisartan—Visual impairment—Topiramate—epilepsy syndrome	3.9e-05	0.000239	CcSEcCtD
Telmisartan—Chest pain—Pregabalin—epilepsy syndrome	3.89e-05	0.000238	CcSEcCtD
Telmisartan—Arthralgia—Pregabalin—epilepsy syndrome	3.89e-05	0.000238	CcSEcCtD
Telmisartan—Myalgia—Pregabalin—epilepsy syndrome	3.89e-05	0.000238	CcSEcCtD
Telmisartan—PPARG—nervous system—epilepsy syndrome	3.89e-05	0.0327	CbGeAlD
Telmisartan—Ill-defined disorder—Gabapentin—epilepsy syndrome	3.89e-05	0.000238	CcSEcCtD
Telmisartan—Dizziness—Zonisamide—epilepsy syndrome	3.89e-05	0.000238	CcSEcCtD
Telmisartan—Headache—Diazepam—epilepsy syndrome	3.89e-05	0.000238	CcSEcCtD
Telmisartan—Anxiety—Pregabalin—epilepsy syndrome	3.88e-05	0.000237	CcSEcCtD
Telmisartan—Diarrhoea—Clonazepam—epilepsy syndrome	3.88e-05	0.000237	CcSEcCtD
Telmisartan—Anaemia—Gabapentin—epilepsy syndrome	3.88e-05	0.000237	CcSEcCtD
Telmisartan—Unspecified disorder of skin and subcutaneous tissue—Pregabalin—epilepsy syndrome	3.87e-05	0.000236	CcSEcCtD
Telmisartan—Hypotension—Valproic Acid—epilepsy syndrome	3.86e-05	0.000236	CcSEcCtD
Telmisartan—Asthenia—Carbamazepine—epilepsy syndrome	3.86e-05	0.000236	CcSEcCtD
Telmisartan—Diarrhoea—Phenytoin—epilepsy syndrome	3.85e-05	0.000235	CcSEcCtD
Telmisartan—Discomfort—Pregabalin—epilepsy syndrome	3.85e-05	0.000235	CcSEcCtD
Telmisartan—Nausea—Fosphenytoin—epilepsy syndrome	3.84e-05	0.000235	CcSEcCtD
Telmisartan—Diarrhoea—Oxcarbazepine—epilepsy syndrome	3.83e-05	0.000234	CcSEcCtD
Telmisartan—Angioedema—Gabapentin—epilepsy syndrome	3.83e-05	0.000234	CcSEcCtD
Telmisartan—Hypersensitivity—Lamotrigine—epilepsy syndrome	3.83e-05	0.000234	CcSEcCtD
Telmisartan—Vomiting—Felbamate—epilepsy syndrome	3.82e-05	0.000234	CcSEcCtD
Telmisartan—Dry mouth—Pregabalin—epilepsy syndrome	3.81e-05	0.000233	CcSEcCtD
Telmisartan—Pruritus—Carbamazepine—epilepsy syndrome	3.8e-05	0.000232	CcSEcCtD
Telmisartan—Rash—Felbamate—epilepsy syndrome	3.79e-05	0.000232	CcSEcCtD
Telmisartan—Eye disorder—Topiramate—epilepsy syndrome	3.79e-05	0.000231	CcSEcCtD
Telmisartan—Dermatitis—Felbamate—epilepsy syndrome	3.79e-05	0.000231	CcSEcCtD
Telmisartan—Malaise—Gabapentin—epilepsy syndrome	3.78e-05	0.000231	CcSEcCtD
Telmisartan—Tinnitus—Topiramate—epilepsy syndrome	3.78e-05	0.000231	CcSEcCtD
Telmisartan—Vertigo—Gabapentin—epilepsy syndrome	3.77e-05	0.00023	CcSEcCtD
Telmisartan—Headache—Felbamate—epilepsy syndrome	3.76e-05	0.00023	CcSEcCtD
Telmisartan—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	3.76e-05	0.00023	CcSEcCtD
Telmisartan—Flushing—Topiramate—epilepsy syndrome	3.76e-05	0.00023	CcSEcCtD
Telmisartan—Cardiac disorder—Topiramate—epilepsy syndrome	3.76e-05	0.00023	CcSEcCtD
Telmisartan—Syncope—Gabapentin—epilepsy syndrome	3.76e-05	0.00023	CcSEcCtD
Telmisartan—Dizziness—Clonazepam—epilepsy syndrome	3.75e-05	0.000229	CcSEcCtD
Telmisartan—PPARG—central nervous system—epilepsy syndrome	3.75e-05	0.0315	CbGeAlD
Telmisartan—Nausea—Vigabatrin—epilepsy syndrome	3.75e-05	0.000229	CcSEcCtD
Telmisartan—Vomiting—Zonisamide—epilepsy syndrome	3.74e-05	0.000229	CcSEcCtD
Telmisartan—Insomnia—Valproic Acid—epilepsy syndrome	3.73e-05	0.000228	CcSEcCtD
Telmisartan—Anaphylactic shock—Pregabalin—epilepsy syndrome	3.73e-05	0.000228	CcSEcCtD
Telmisartan—Oedema—Pregabalin—epilepsy syndrome	3.73e-05	0.000228	CcSEcCtD
Telmisartan—Asthenia—Lamotrigine—epilepsy syndrome	3.73e-05	0.000228	CcSEcCtD
Telmisartan—Dizziness—Phenytoin—epilepsy syndrome	3.72e-05	0.000228	CcSEcCtD
Telmisartan—Rash—Zonisamide—epilepsy syndrome	3.71e-05	0.000227	CcSEcCtD
Telmisartan—Infection—Pregabalin—epilepsy syndrome	3.71e-05	0.000227	CcSEcCtD
Telmisartan—Paraesthesia—Valproic Acid—epilepsy syndrome	3.71e-05	0.000227	CcSEcCtD
Telmisartan—Palpitations—Gabapentin—epilepsy syndrome	3.71e-05	0.000226	CcSEcCtD
Telmisartan—Dermatitis—Zonisamide—epilepsy syndrome	3.7e-05	0.000226	CcSEcCtD
Telmisartan—Dizziness—Oxcarbazepine—epilepsy syndrome	3.7e-05	0.000226	CcSEcCtD
Telmisartan—Nausea—Diazepam—epilepsy syndrome	3.69e-05	0.000225	CcSEcCtD
Telmisartan—Loss of consciousness—Gabapentin—epilepsy syndrome	3.68e-05	0.000225	CcSEcCtD
Telmisartan—Headache—Zonisamide—epilepsy syndrome	3.68e-05	0.000225	CcSEcCtD
Telmisartan—Dyspnoea—Valproic Acid—epilepsy syndrome	3.68e-05	0.000225	CcSEcCtD
Telmisartan—Diarrhoea—Carbamazepine—epilepsy syndrome	3.68e-05	0.000225	CcSEcCtD
Telmisartan—Angiopathy—Topiramate—epilepsy syndrome	3.68e-05	0.000225	CcSEcCtD
Telmisartan—Pruritus—Lamotrigine—epilepsy syndrome	3.67e-05	0.000225	CcSEcCtD
Telmisartan—Shock—Pregabalin—epilepsy syndrome	3.67e-05	0.000224	CcSEcCtD
Telmisartan—Somnolence—Valproic Acid—epilepsy syndrome	3.67e-05	0.000224	CcSEcCtD
Telmisartan—Immune system disorder—Topiramate—epilepsy syndrome	3.66e-05	0.000224	CcSEcCtD
Telmisartan—Nervous system disorder—Pregabalin—epilepsy syndrome	3.66e-05	0.000224	CcSEcCtD
Telmisartan—Cough—Gabapentin—epilepsy syndrome	3.66e-05	0.000224	CcSEcCtD
Telmisartan—Thrombocytopenia—Pregabalin—epilepsy syndrome	3.65e-05	0.000223	CcSEcCtD
Telmisartan—Mediastinal disorder—Topiramate—epilepsy syndrome	3.65e-05	0.000223	CcSEcCtD
Telmisartan—Tachycardia—Pregabalin—epilepsy syndrome	3.64e-05	0.000223	CcSEcCtD
Telmisartan—Chills—Topiramate—epilepsy syndrome	3.64e-05	0.000222	CcSEcCtD
Telmisartan—Dyspepsia—Valproic Acid—epilepsy syndrome	3.63e-05	0.000222	CcSEcCtD
Telmisartan—Skin disorder—Pregabalin—epilepsy syndrome	3.62e-05	0.000222	CcSEcCtD
Telmisartan—Hypertension—Gabapentin—epilepsy syndrome	3.62e-05	0.000221	CcSEcCtD
Telmisartan—AGTR1—brain—epilepsy syndrome	3.62e-05	0.0304	CbGeAlD
Telmisartan—Hyperhidrosis—Pregabalin—epilepsy syndrome	3.61e-05	0.00022	CcSEcCtD
Telmisartan—Vomiting—Clonazepam—epilepsy syndrome	3.6e-05	0.00022	CcSEcCtD
Telmisartan—Decreased appetite—Valproic Acid—epilepsy syndrome	3.59e-05	0.000219	CcSEcCtD
Telmisartan—Vomiting—Phenytoin—epilepsy syndrome	3.58e-05	0.000219	CcSEcCtD
Telmisartan—Rash—Clonazepam—epilepsy syndrome	3.57e-05	0.000218	CcSEcCtD
Telmisartan—Dermatitis—Clonazepam—epilepsy syndrome	3.57e-05	0.000218	CcSEcCtD
Telmisartan—Myalgia—Gabapentin—epilepsy syndrome	3.57e-05	0.000218	CcSEcCtD
Telmisartan—Arthralgia—Gabapentin—epilepsy syndrome	3.57e-05	0.000218	CcSEcCtD
Telmisartan—Chest pain—Gabapentin—epilepsy syndrome	3.57e-05	0.000218	CcSEcCtD
Telmisartan—Nausea—Felbamate—epilepsy syndrome	3.57e-05	0.000218	CcSEcCtD
Telmisartan—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	3.56e-05	0.000218	CcSEcCtD
Telmisartan—Vomiting—Oxcarbazepine—epilepsy syndrome	3.56e-05	0.000218	CcSEcCtD
Telmisartan—Fatigue—Valproic Acid—epilepsy syndrome	3.56e-05	0.000218	CcSEcCtD
Telmisartan—Anxiety—Gabapentin—epilepsy syndrome	3.56e-05	0.000217	CcSEcCtD
Telmisartan—Anorexia—Pregabalin—epilepsy syndrome	3.56e-05	0.000217	CcSEcCtD
Telmisartan—Dizziness—Carbamazepine—epilepsy syndrome	3.55e-05	0.000217	CcSEcCtD
Telmisartan—Diarrhoea—Lamotrigine—epilepsy syndrome	3.55e-05	0.000217	CcSEcCtD
Telmisartan—Headache—Clonazepam—epilepsy syndrome	3.55e-05	0.000217	CcSEcCtD
Telmisartan—Rash—Phenytoin—epilepsy syndrome	3.55e-05	0.000217	CcSEcCtD
Telmisartan—Mental disorder—Topiramate—epilepsy syndrome	3.55e-05	0.000217	CcSEcCtD
Telmisartan—Dermatitis—Phenytoin—epilepsy syndrome	3.55e-05	0.000217	CcSEcCtD
Telmisartan—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	3.54e-05	0.000217	CcSEcCtD
Telmisartan—Rash—Oxcarbazepine—epilepsy syndrome	3.53e-05	0.000216	CcSEcCtD
Telmisartan—Pain—Valproic Acid—epilepsy syndrome	3.53e-05	0.000216	CcSEcCtD
Telmisartan—Constipation—Valproic Acid—epilepsy syndrome	3.53e-05	0.000216	CcSEcCtD
Telmisartan—Dermatitis—Oxcarbazepine—epilepsy syndrome	3.53e-05	0.000216	CcSEcCtD
Telmisartan—Headache—Phenytoin—epilepsy syndrome	3.53e-05	0.000216	CcSEcCtD
Telmisartan—Malnutrition—Topiramate—epilepsy syndrome	3.53e-05	0.000216	CcSEcCtD
Telmisartan—Erythema—Topiramate—epilepsy syndrome	3.53e-05	0.000216	CcSEcCtD
Telmisartan—Discomfort—Gabapentin—epilepsy syndrome	3.53e-05	0.000216	CcSEcCtD
Telmisartan—Headache—Oxcarbazepine—epilepsy syndrome	3.51e-05	0.000214	CcSEcCtD
Telmisartan—Nausea—Zonisamide—epilepsy syndrome	3.49e-05	0.000214	CcSEcCtD
Telmisartan—Dry mouth—Gabapentin—epilepsy syndrome	3.49e-05	0.000213	CcSEcCtD
Telmisartan—Hypotension—Pregabalin—epilepsy syndrome	3.49e-05	0.000213	CcSEcCtD
Telmisartan—Flatulence—Topiramate—epilepsy syndrome	3.48e-05	0.000212	CcSEcCtD
Telmisartan—Tension—Topiramate—epilepsy syndrome	3.46e-05	0.000212	CcSEcCtD
Telmisartan—Dysgeusia—Topiramate—epilepsy syndrome	3.45e-05	0.000211	CcSEcCtD
Telmisartan—Dizziness—Lamotrigine—epilepsy syndrome	3.43e-05	0.00021	CcSEcCtD
Telmisartan—Nervousness—Topiramate—epilepsy syndrome	3.43e-05	0.000209	CcSEcCtD
Telmisartan—Anaphylactic shock—Gabapentin—epilepsy syndrome	3.42e-05	0.000209	CcSEcCtD
Telmisartan—Oedema—Gabapentin—epilepsy syndrome	3.42e-05	0.000209	CcSEcCtD
Telmisartan—Vomiting—Carbamazepine—epilepsy syndrome	3.42e-05	0.000209	CcSEcCtD
Telmisartan—Back pain—Topiramate—epilepsy syndrome	3.41e-05	0.000209	CcSEcCtD
Telmisartan—Feeling abnormal—Valproic Acid—epilepsy syndrome	3.4e-05	0.000208	CcSEcCtD
Telmisartan—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	3.4e-05	0.000208	CcSEcCtD
Telmisartan—Infection—Gabapentin—epilepsy syndrome	3.4e-05	0.000208	CcSEcCtD
Telmisartan—Muscle spasms—Topiramate—epilepsy syndrome	3.39e-05	0.000207	CcSEcCtD
Telmisartan—Rash—Carbamazepine—epilepsy syndrome	3.39e-05	0.000207	CcSEcCtD
Telmisartan—Dermatitis—Carbamazepine—epilepsy syndrome	3.39e-05	0.000207	CcSEcCtD
Telmisartan—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	3.38e-05	0.000206	CcSEcCtD
Telmisartan—Insomnia—Pregabalin—epilepsy syndrome	3.38e-05	0.000206	CcSEcCtD
Telmisartan—Nausea—Clonazepam—epilepsy syndrome	3.37e-05	0.000206	CcSEcCtD
Telmisartan—Headache—Carbamazepine—epilepsy syndrome	3.37e-05	0.000206	CcSEcCtD
Telmisartan—Shock—Gabapentin—epilepsy syndrome	3.37e-05	0.000206	CcSEcCtD
Telmisartan—Nervous system disorder—Gabapentin—epilepsy syndrome	3.36e-05	0.000205	CcSEcCtD
Telmisartan—Paraesthesia—Pregabalin—epilepsy syndrome	3.35e-05	0.000205	CcSEcCtD
Telmisartan—Thrombocytopenia—Gabapentin—epilepsy syndrome	3.35e-05	0.000205	CcSEcCtD
Telmisartan—Nausea—Phenytoin—epilepsy syndrome	3.34e-05	0.000204	CcSEcCtD
Telmisartan—Tachycardia—Gabapentin—epilepsy syndrome	3.34e-05	0.000204	CcSEcCtD
Telmisartan—Dyspnoea—Pregabalin—epilepsy syndrome	3.33e-05	0.000203	CcSEcCtD
Telmisartan—Nausea—Oxcarbazepine—epilepsy syndrome	3.33e-05	0.000203	CcSEcCtD
Telmisartan—Skin disorder—Gabapentin—epilepsy syndrome	3.32e-05	0.000203	CcSEcCtD
Telmisartan—ABCG2—medulla oblongata—epilepsy syndrome	3.32e-05	0.0279	CbGeAlD
Telmisartan—Somnolence—Pregabalin—epilepsy syndrome	3.32e-05	0.000203	CcSEcCtD
Telmisartan—Hyperhidrosis—Gabapentin—epilepsy syndrome	3.31e-05	0.000202	CcSEcCtD
Telmisartan—Vomiting—Lamotrigine—epilepsy syndrome	3.3e-05	0.000202	CcSEcCtD
Telmisartan—Urticaria—Valproic Acid—epilepsy syndrome	3.28e-05	0.0002	CcSEcCtD
Telmisartan—Rash—Lamotrigine—epilepsy syndrome	3.28e-05	0.0002	CcSEcCtD
Telmisartan—Ill-defined disorder—Topiramate—epilepsy syndrome	3.27e-05	0.0002	CcSEcCtD
Telmisartan—Dermatitis—Lamotrigine—epilepsy syndrome	3.27e-05	0.0002	CcSEcCtD
Telmisartan—Abdominal pain—Valproic Acid—epilepsy syndrome	3.26e-05	0.000199	CcSEcCtD
Telmisartan—Body temperature increased—Valproic Acid—epilepsy syndrome	3.26e-05	0.000199	CcSEcCtD
Telmisartan—Anorexia—Gabapentin—epilepsy syndrome	3.26e-05	0.000199	CcSEcCtD
Telmisartan—Anaemia—Topiramate—epilepsy syndrome	3.26e-05	0.000199	CcSEcCtD
Telmisartan—Headache—Lamotrigine—epilepsy syndrome	3.25e-05	0.000199	CcSEcCtD
Telmisartan—Decreased appetite—Pregabalin—epilepsy syndrome	3.24e-05	0.000198	CcSEcCtD
Telmisartan—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	3.22e-05	0.000197	CcSEcCtD
Telmisartan—Fatigue—Pregabalin—epilepsy syndrome	3.22e-05	0.000197	CcSEcCtD
Telmisartan—Hypotension—Gabapentin—epilepsy syndrome	3.2e-05	0.000195	CcSEcCtD
Telmisartan—Nausea—Carbamazepine—epilepsy syndrome	3.19e-05	0.000195	CcSEcCtD
Telmisartan—Pain—Pregabalin—epilepsy syndrome	3.19e-05	0.000195	CcSEcCtD
Telmisartan—Constipation—Pregabalin—epilepsy syndrome	3.19e-05	0.000195	CcSEcCtD
Telmisartan—Malaise—Topiramate—epilepsy syndrome	3.18e-05	0.000194	CcSEcCtD
Telmisartan—Vertigo—Topiramate—epilepsy syndrome	3.17e-05	0.000194	CcSEcCtD
Telmisartan—Syncope—Topiramate—epilepsy syndrome	3.16e-05	0.000193	CcSEcCtD
Telmisartan—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	3.12e-05	0.000191	CcSEcCtD
Telmisartan—Palpitations—Topiramate—epilepsy syndrome	3.12e-05	0.000191	CcSEcCtD
Telmisartan—Loss of consciousness—Topiramate—epilepsy syndrome	3.1e-05	0.000189	CcSEcCtD
Telmisartan—Insomnia—Gabapentin—epilepsy syndrome	3.09e-05	0.000189	CcSEcCtD
Telmisartan—Nausea—Lamotrigine—epilepsy syndrome	3.09e-05	0.000189	CcSEcCtD
Telmisartan—Cough—Topiramate—epilepsy syndrome	3.08e-05	0.000188	CcSEcCtD
Telmisartan—Feeling abnormal—Pregabalin—epilepsy syndrome	3.08e-05	0.000188	CcSEcCtD
Telmisartan—Paraesthesia—Gabapentin—epilepsy syndrome	3.07e-05	0.000188	CcSEcCtD
Telmisartan—Gastrointestinal pain—Pregabalin—epilepsy syndrome	3.05e-05	0.000187	CcSEcCtD
Telmisartan—Dyspnoea—Gabapentin—epilepsy syndrome	3.05e-05	0.000186	CcSEcCtD
Telmisartan—Hypertension—Topiramate—epilepsy syndrome	3.05e-05	0.000186	CcSEcCtD
Telmisartan—Somnolence—Gabapentin—epilepsy syndrome	3.04e-05	0.000186	CcSEcCtD
Telmisartan—Hypersensitivity—Valproic Acid—epilepsy syndrome	3.04e-05	0.000186	CcSEcCtD
Telmisartan—ABCG2—midbrain—epilepsy syndrome	3.03e-05	0.0255	CbGeAlD
Telmisartan—Dyspepsia—Gabapentin—epilepsy syndrome	3.01e-05	0.000184	CcSEcCtD
Telmisartan—Chest pain—Topiramate—epilepsy syndrome	3e-05	0.000184	CcSEcCtD
Telmisartan—Myalgia—Topiramate—epilepsy syndrome	3e-05	0.000184	CcSEcCtD
Telmisartan—Arthralgia—Topiramate—epilepsy syndrome	3e-05	0.000184	CcSEcCtD
Telmisartan—Anxiety—Topiramate—epilepsy syndrome	2.99e-05	0.000183	CcSEcCtD
Telmisartan—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	2.98e-05	0.000182	CcSEcCtD
Telmisartan—PPARG—brain—epilepsy syndrome	2.98e-05	0.025	CbGeAlD
Telmisartan—Decreased appetite—Gabapentin—epilepsy syndrome	2.97e-05	0.000182	CcSEcCtD
Telmisartan—Discomfort—Topiramate—epilepsy syndrome	2.97e-05	0.000181	CcSEcCtD
Telmisartan—Urticaria—Pregabalin—epilepsy syndrome	2.96e-05	0.000181	CcSEcCtD
Telmisartan—Asthenia—Valproic Acid—epilepsy syndrome	2.96e-05	0.000181	CcSEcCtD
Telmisartan—ABCG2—spinal cord—epilepsy syndrome	2.96e-05	0.0249	CbGeAlD
Telmisartan—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	2.95e-05	0.000181	CcSEcCtD
Telmisartan—Fatigue—Gabapentin—epilepsy syndrome	2.95e-05	0.00018	CcSEcCtD
Telmisartan—Body temperature increased—Pregabalin—epilepsy syndrome	2.95e-05	0.00018	CcSEcCtD
Telmisartan—Abdominal pain—Pregabalin—epilepsy syndrome	2.95e-05	0.00018	CcSEcCtD
Telmisartan—Dry mouth—Topiramate—epilepsy syndrome	2.94e-05	0.00018	CcSEcCtD
Telmisartan—Pain—Gabapentin—epilepsy syndrome	2.93e-05	0.000179	CcSEcCtD
Telmisartan—Constipation—Gabapentin—epilepsy syndrome	2.93e-05	0.000179	CcSEcCtD
Telmisartan—Pruritus—Valproic Acid—epilepsy syndrome	2.92e-05	0.000178	CcSEcCtD
Telmisartan—Oedema—Topiramate—epilepsy syndrome	2.88e-05	0.000176	CcSEcCtD
Telmisartan—Infection—Topiramate—epilepsy syndrome	2.86e-05	0.000175	CcSEcCtD
Telmisartan—Shock—Topiramate—epilepsy syndrome	2.83e-05	0.000173	CcSEcCtD
Telmisartan—Diarrhoea—Valproic Acid—epilepsy syndrome	2.82e-05	0.000173	CcSEcCtD
Telmisartan—Nervous system disorder—Topiramate—epilepsy syndrome	2.82e-05	0.000173	CcSEcCtD
Telmisartan—Feeling abnormal—Gabapentin—epilepsy syndrome	2.82e-05	0.000172	CcSEcCtD
Telmisartan—Thrombocytopenia—Topiramate—epilepsy syndrome	2.82e-05	0.000172	CcSEcCtD
Telmisartan—Tachycardia—Topiramate—epilepsy syndrome	2.81e-05	0.000172	CcSEcCtD
Telmisartan—Gastrointestinal pain—Gabapentin—epilepsy syndrome	2.8e-05	0.000171	CcSEcCtD
Telmisartan—Skin disorder—Topiramate—epilepsy syndrome	2.8e-05	0.000171	CcSEcCtD
Telmisartan—Hyperhidrosis—Topiramate—epilepsy syndrome	2.78e-05	0.00017	CcSEcCtD
Telmisartan—Hypersensitivity—Pregabalin—epilepsy syndrome	2.75e-05	0.000168	CcSEcCtD
Telmisartan—Anorexia—Topiramate—epilepsy syndrome	2.74e-05	0.000168	CcSEcCtD
Telmisartan—Dizziness—Valproic Acid—epilepsy syndrome	2.73e-05	0.000167	CcSEcCtD
Telmisartan—Urticaria—Gabapentin—epilepsy syndrome	2.72e-05	0.000166	CcSEcCtD
Telmisartan—Body temperature increased—Gabapentin—epilepsy syndrome	2.7e-05	0.000165	CcSEcCtD
Telmisartan—Abdominal pain—Gabapentin—epilepsy syndrome	2.7e-05	0.000165	CcSEcCtD
Telmisartan—Hypotension—Topiramate—epilepsy syndrome	2.69e-05	0.000164	CcSEcCtD
Telmisartan—Asthenia—Pregabalin—epilepsy syndrome	2.68e-05	0.000164	CcSEcCtD
Telmisartan—Pruritus—Pregabalin—epilepsy syndrome	2.64e-05	0.000161	CcSEcCtD
Telmisartan—Vomiting—Valproic Acid—epilepsy syndrome	2.62e-05	0.00016	CcSEcCtD
Telmisartan—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	2.62e-05	0.00016	CcSEcCtD
Telmisartan—Insomnia—Topiramate—epilepsy syndrome	2.6e-05	0.000159	CcSEcCtD
Telmisartan—Rash—Valproic Acid—epilepsy syndrome	2.6e-05	0.000159	CcSEcCtD
Telmisartan—Dermatitis—Valproic Acid—epilepsy syndrome	2.6e-05	0.000159	CcSEcCtD
Telmisartan—Headache—Valproic Acid—epilepsy syndrome	2.59e-05	0.000158	CcSEcCtD
Telmisartan—Paraesthesia—Topiramate—epilepsy syndrome	2.58e-05	0.000158	CcSEcCtD
Telmisartan—Dyspnoea—Topiramate—epilepsy syndrome	2.57e-05	0.000157	CcSEcCtD
Telmisartan—Somnolence—Topiramate—epilepsy syndrome	2.56e-05	0.000156	CcSEcCtD
Telmisartan—Diarrhoea—Pregabalin—epilepsy syndrome	2.55e-05	0.000156	CcSEcCtD
Telmisartan—Dyspepsia—Topiramate—epilepsy syndrome	2.53e-05	0.000155	CcSEcCtD
Telmisartan—Hypersensitivity—Gabapentin—epilepsy syndrome	2.52e-05	0.000154	CcSEcCtD
Telmisartan—Decreased appetite—Topiramate—epilepsy syndrome	2.5e-05	0.000153	CcSEcCtD
Telmisartan—Gastrointestinal disorder—Topiramate—epilepsy syndrome	2.49e-05	0.000152	CcSEcCtD
Telmisartan—Fatigue—Topiramate—epilepsy syndrome	2.48e-05	0.000152	CcSEcCtD
Telmisartan—Dizziness—Pregabalin—epilepsy syndrome	2.47e-05	0.000151	CcSEcCtD
Telmisartan—Pain—Topiramate—epilepsy syndrome	2.46e-05	0.00015	CcSEcCtD
Telmisartan—Constipation—Topiramate—epilepsy syndrome	2.46e-05	0.00015	CcSEcCtD
Telmisartan—Asthenia—Gabapentin—epilepsy syndrome	2.46e-05	0.00015	CcSEcCtD
Telmisartan—Nausea—Valproic Acid—epilepsy syndrome	2.45e-05	0.00015	CcSEcCtD
Telmisartan—Pruritus—Gabapentin—epilepsy syndrome	2.42e-05	0.000148	CcSEcCtD
Telmisartan—Vomiting—Pregabalin—epilepsy syndrome	2.37e-05	0.000145	CcSEcCtD
Telmisartan—Feeling abnormal—Topiramate—epilepsy syndrome	2.37e-05	0.000145	CcSEcCtD
Telmisartan—Gastrointestinal pain—Topiramate—epilepsy syndrome	2.35e-05	0.000144	CcSEcCtD
Telmisartan—Rash—Pregabalin—epilepsy syndrome	2.35e-05	0.000144	CcSEcCtD
Telmisartan—Dermatitis—Pregabalin—epilepsy syndrome	2.35e-05	0.000144	CcSEcCtD
Telmisartan—ABCG2—cerebellum—epilepsy syndrome	2.35e-05	0.0197	CbGeAlD
Telmisartan—Diarrhoea—Gabapentin—epilepsy syndrome	2.34e-05	0.000143	CcSEcCtD
Telmisartan—Headache—Pregabalin—epilepsy syndrome	2.34e-05	0.000143	CcSEcCtD
Telmisartan—Urticaria—Topiramate—epilepsy syndrome	2.29e-05	0.00014	CcSEcCtD
Telmisartan—Abdominal pain—Topiramate—epilepsy syndrome	2.28e-05	0.000139	CcSEcCtD
Telmisartan—Body temperature increased—Topiramate—epilepsy syndrome	2.28e-05	0.000139	CcSEcCtD
Telmisartan—ABCB1—forebrain—epilepsy syndrome	2.27e-05	0.019	CbGeAlD
Telmisartan—Dizziness—Gabapentin—epilepsy syndrome	2.26e-05	0.000138	CcSEcCtD
Telmisartan—Nausea—Pregabalin—epilepsy syndrome	2.22e-05	0.000135	CcSEcCtD
Telmisartan—Vomiting—Gabapentin—epilepsy syndrome	2.18e-05	0.000133	CcSEcCtD
Telmisartan—Rash—Gabapentin—epilepsy syndrome	2.16e-05	0.000132	CcSEcCtD
Telmisartan—Dermatitis—Gabapentin—epilepsy syndrome	2.16e-05	0.000132	CcSEcCtD
Telmisartan—Headache—Gabapentin—epilepsy syndrome	2.14e-05	0.000131	CcSEcCtD
Telmisartan—Hypersensitivity—Topiramate—epilepsy syndrome	2.12e-05	0.00013	CcSEcCtD
Telmisartan—ABCB1—telencephalon—epilepsy syndrome	2.08e-05	0.0175	CbGeAlD
Telmisartan—Asthenia—Topiramate—epilepsy syndrome	2.07e-05	0.000126	CcSEcCtD
Telmisartan—Pruritus—Topiramate—epilepsy syndrome	2.04e-05	0.000124	CcSEcCtD
Telmisartan—Nausea—Gabapentin—epilepsy syndrome	2.03e-05	0.000124	CcSEcCtD
Telmisartan—Diarrhoea—Topiramate—epilepsy syndrome	1.97e-05	0.00012	CcSEcCtD
Telmisartan—ABCG2—brain—epilepsy syndrome	1.91e-05	0.016	CbGeAlD
Telmisartan—Dizziness—Topiramate—epilepsy syndrome	1.9e-05	0.000116	CcSEcCtD
Telmisartan—Vomiting—Topiramate—epilepsy syndrome	1.83e-05	0.000112	CcSEcCtD
Telmisartan—Rash—Topiramate—epilepsy syndrome	1.82e-05	0.000111	CcSEcCtD
Telmisartan—Dermatitis—Topiramate—epilepsy syndrome	1.81e-05	0.000111	CcSEcCtD
Telmisartan—Headache—Topiramate—epilepsy syndrome	1.8e-05	0.00011	CcSEcCtD
Telmisartan—Nausea—Topiramate—epilepsy syndrome	1.71e-05	0.000105	CcSEcCtD
Telmisartan—ABCB1—medulla oblongata—epilepsy syndrome	1.64e-05	0.0138	CbGeAlD
Telmisartan—ABCB1—midbrain—epilepsy syndrome	1.5e-05	0.0126	CbGeAlD
Telmisartan—ABCB1—spinal cord—epilepsy syndrome	1.46e-05	0.0123	CbGeAlD
Telmisartan—ABCB1—head—epilepsy syndrome	1.3e-05	0.0109	CbGeAlD
Telmisartan—ABCB1—nervous system—epilepsy syndrome	1.23e-05	0.0103	CbGeAlD
Telmisartan—ABCB1—central nervous system—epilepsy syndrome	1.18e-05	0.00995	CbGeAlD
Telmisartan—PPARG—Metabolism—ABCG2—epilepsy syndrome	1.16e-05	0.000169	CbGpPWpGaD
Telmisartan—ABCB1—cerebellum—epilepsy syndrome	1.16e-05	0.00973	CbGeAlD
Telmisartan—ABCB1—Allograft Rejection—TNF—epilepsy syndrome	1.15e-05	0.000167	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—QDPR—epilepsy syndrome	1.15e-05	0.000167	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—CA4—epilepsy syndrome	1.15e-05	0.000167	CbGpPWpGaD
Telmisartan—ABCB1—Transmembrane transport of small molecules—ABCC2—epilepsy syndrome	1.15e-05	0.000167	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—AQP1—epilepsy syndrome	1.15e-05	0.000167	CbGpPWpGaD
Telmisartan—AGTR1—GPCR downstream signaling—PRKCB—epilepsy syndrome	1.14e-05	0.000166	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—TSC1—epilepsy syndrome	1.14e-05	0.000166	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—PTK2B—epilepsy syndrome	1.14e-05	0.000166	CbGpPWpGaD
Telmisartan—SLCO1B3—Transmembrane transport of small molecules—ALB—epilepsy syndrome	1.13e-05	0.000165	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—ADRA2A—epilepsy syndrome	1.13e-05	0.000165	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—CYP2C19—epilepsy syndrome	1.13e-05	0.000165	CbGpPWpGaD
Telmisartan—ABCG2—Transmembrane transport of small molecules—ABCB1—epilepsy syndrome	1.13e-05	0.000164	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—BCHE—epilepsy syndrome	1.12e-05	0.000164	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—CYP11A1—epilepsy syndrome	1.12e-05	0.000164	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—AGT—epilepsy syndrome	1.12e-05	0.000163	CbGpPWpGaD
Telmisartan—PPARG—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	1.11e-05	0.000162	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—CCR2—epilepsy syndrome	1.11e-05	0.000161	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—SST—epilepsy syndrome	1.11e-05	0.000161	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—NTRK2—epilepsy syndrome	1.11e-05	0.000161	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—COX3—epilepsy syndrome	1.1e-05	0.000161	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—FGF2—epilepsy syndrome	1.1e-05	0.000161	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—DUSP6—epilepsy syndrome	1.1e-05	0.00016	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—ADRA2A—epilepsy syndrome	1.08e-05	0.000158	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—COX3—epilepsy syndrome	1.08e-05	0.000157	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—PLAT—epilepsy syndrome	1.08e-05	0.000157	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—SLC2A1—epilepsy syndrome	1.07e-05	0.000156	CbGpPWpGaD
Telmisartan—ABCB1—Transmembrane transport of small molecules—SLC6A1—epilepsy syndrome	1.07e-05	0.000155	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—PLCB1—epilepsy syndrome	1.06e-05	0.000155	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—TH—epilepsy syndrome	1.06e-05	0.000154	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—SLCO1A2—epilepsy syndrome	1.05e-05	0.000153	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—PFKL—epilepsy syndrome	1.05e-05	0.000153	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—KCNB1—epilepsy syndrome	1.05e-05	0.000153	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—CACNA2D2—epilepsy syndrome	1.05e-05	0.000153	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—SLC6A8—epilepsy syndrome	1.05e-05	0.000153	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	1.04e-05	0.000152	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—BDKRB2—epilepsy syndrome	1.04e-05	0.000152	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—CXCL12—epilepsy syndrome	1.04e-05	0.000152	CbGpPWpGaD
Telmisartan—AGTR1—GPCR downstream signaling—POMC—epilepsy syndrome	1.04e-05	0.000151	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—CHRM3—epilepsy syndrome	1.04e-05	0.000151	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—KCNJ11—epilepsy syndrome	1.04e-05	0.000151	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—PRKCB—epilepsy syndrome	1.04e-05	0.000151	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—IL6ST—epilepsy syndrome	1.03e-05	0.00015	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—epilepsy syndrome	1.03e-05	0.00015	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—RELA—epilepsy syndrome	1.02e-05	0.000149	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—KCNB1—epilepsy syndrome	1.02e-05	0.000149	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—PFKL—epilepsy syndrome	1.02e-05	0.000149	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—CACNA2D2—epilepsy syndrome	1.02e-05	0.000149	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—SLCO1A2—epilepsy syndrome	1.02e-05	0.000149	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—SLC6A8—epilepsy syndrome	1.02e-05	0.000149	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—CNR1—epilepsy syndrome	1.02e-05	0.000149	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—JUNB—epilepsy syndrome	1.02e-05	0.000149	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—CYP11A1—epilepsy syndrome	1.02e-05	0.000148	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—PLCB1—epilepsy syndrome	1.02e-05	0.000148	CbGpPWpGaD
Telmisartan—PPARG—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	1.02e-05	0.000148	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—CYP2D6—epilepsy syndrome	1.01e-05	0.000148	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—HTR7—epilepsy syndrome	9.96e-06	0.000145	CbGpPWpGaD
Telmisartan—ABCB1—HIF-1-alpha transcription factor network—AKT1—epilepsy syndrome	9.86e-06	0.000144	CbGpPWpGaD
Telmisartan—ABCB1—Transmembrane transport of small molecules—ABCG2—epilepsy syndrome	9.75e-06	0.000142	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—HBEGF—epilepsy syndrome	9.67e-06	0.000141	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—ADRA2A—epilepsy syndrome	9.64e-06	0.000141	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—BCHE—epilepsy syndrome	9.6e-06	0.00014	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—UPB1—epilepsy syndrome	9.58e-06	0.00014	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—NEU1—epilepsy syndrome	9.58e-06	0.00014	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—ATIC—epilepsy syndrome	9.58e-06	0.00014	CbGpPWpGaD
Telmisartan—ABCB1—Transmembrane transport of small molecules—ATP2A2—epilepsy syndrome	9.5e-06	0.000138	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—AKT3—epilepsy syndrome	9.49e-06	0.000138	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—POMC—epilepsy syndrome	9.43e-06	0.000137	CbGpPWpGaD
Telmisartan—PPARG—Gene Expression—SIRT1—epilepsy syndrome	9.41e-06	0.000137	CbGpPWpGaD
Telmisartan—ABCB1—brain—epilepsy syndrome	9.4e-06	0.0079	CbGeAlD
Telmisartan—ABCB1—Metabolism—UPB1—epilepsy syndrome	9.35e-06	0.000136	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—ATIC—epilepsy syndrome	9.35e-06	0.000136	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—NEU1—epilepsy syndrome	9.35e-06	0.000136	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—FGF2—epilepsy syndrome	9.3e-06	0.000136	CbGpPWpGaD
Telmisartan—PPARG—Gene Expression—VDR—epilepsy syndrome	9.28e-06	0.000135	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—ADAM10—epilepsy syndrome	9.27e-06	0.000135	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—CCL2—epilepsy syndrome	9.23e-06	0.000135	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—HSD17B4—epilepsy syndrome	9.22e-06	0.000134	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—SLC2A1—epilepsy syndrome	9.15e-06	0.000133	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—PLCB1—epilepsy syndrome	9.05e-06	0.000132	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—TH—epilepsy syndrome	9.02e-06	0.000132	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—HSD17B4—epilepsy syndrome	9e-06	0.000131	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—PPP1R3C—epilepsy syndrome	8.9e-06	0.00013	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—GBE1—epilepsy syndrome	8.9e-06	0.00013	CbGpPWpGaD
Telmisartan—PPARG—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	8.88e-06	0.00013	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—epilepsy syndrome	8.83e-06	0.000129	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—HMOX1—epilepsy syndrome	8.82e-06	0.000129	CbGpPWpGaD
Telmisartan—PPARG—Gene Expression—H2AFX—epilepsy syndrome	8.79e-06	0.000128	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—S100B—epilepsy syndrome	8.76e-06	0.000128	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—MMP9—epilepsy syndrome	8.72e-06	0.000127	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—CAT—epilepsy syndrome	8.71e-06	0.000127	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—epilepsy syndrome	8.7e-06	0.000127	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—GBE1—epilepsy syndrome	8.69e-06	0.000127	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—PPP1R3C—epilepsy syndrome	8.69e-06	0.000127	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—SOCS3—epilepsy syndrome	8.68e-06	0.000127	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—CDC42—epilepsy syndrome	8.66e-06	0.000126	CbGpPWpGaD
Telmisartan—PPARG—Gene Expression—YWHAZ—epilepsy syndrome	8.48e-06	0.000124	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—ABCB1—epilepsy syndrome	8.47e-06	0.000124	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—epilepsy syndrome	8.38e-06	0.000122	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—AVP—epilepsy syndrome	8.38e-06	0.000122	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—ASAH1—epilepsy syndrome	8.37e-06	0.000122	CbGpPWpGaD
Telmisartan—PPARG—Gene Expression—NR3C1—epilepsy syndrome	8.35e-06	0.000122	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—CYP2C19—epilepsy syndrome	8.23e-06	0.00012	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—CYP11A1—epilepsy syndrome	8.18e-06	0.000119	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—ASAH1—epilepsy syndrome	8.17e-06	0.000119	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—STXBP1—epilepsy syndrome	8.14e-06	0.000119	CbGpPWpGaD
Telmisartan—ABCC2—Transmembrane transport of small molecules—ALB—epilepsy syndrome	8.09e-06	0.000118	CbGpPWpGaD
Telmisartan—ABCB1—Transmembrane transport of small molecules—PLAT—epilepsy syndrome	8.08e-06	0.000118	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—SRC—epilepsy syndrome	8.04e-06	0.000117	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—STXBP1—epilepsy syndrome	7.95e-06	0.000116	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—NT5E—epilepsy syndrome	7.94e-06	0.000116	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—ALAD—epilepsy syndrome	7.94e-06	0.000116	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—HES1—epilepsy syndrome	7.93e-06	0.000116	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—GPX1—epilepsy syndrome	7.87e-06	0.000115	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—VEGFA—epilepsy syndrome	7.83e-06	0.000114	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—epilepsy syndrome	7.78e-06	0.000113	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—ALAD—epilepsy syndrome	7.75e-06	0.000113	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—NT5E—epilepsy syndrome	7.75e-06	0.000113	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—FYN—epilepsy syndrome	7.71e-06	0.000112	CbGpPWpGaD
Telmisartan—ABCB1—Transmembrane transport of small molecules—SLC2A1—epilepsy syndrome	7.7e-06	0.000112	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—H2AFX—epilepsy syndrome	7.68e-06	0.000112	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—MEF2C—epilepsy syndrome	7.67e-06	0.000112	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—CACNA1A—epilepsy syndrome	7.57e-06	0.00011	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—ALDH7A1—epilepsy syndrome	7.57e-06	0.00011	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—epilepsy syndrome	7.56e-06	0.00011	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—HMOX1—epilepsy syndrome	7.53e-06	0.00011	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—CAT—epilepsy syndrome	7.43e-06	0.000108	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—YWHAZ—epilepsy syndrome	7.41e-06	0.000108	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—ST3GAL3—epilepsy syndrome	7.41e-06	0.000108	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—ALDH7A1—epilepsy syndrome	7.39e-06	0.000108	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—CACNA1A—epilepsy syndrome	7.39e-06	0.000108	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—CYP2D6—epilepsy syndrome	7.38e-06	0.000108	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—NGF—epilepsy syndrome	7.33e-06	0.000107	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—ADSL—epilepsy syndrome	7.26e-06	0.000106	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—ST3GAL3—epilepsy syndrome	7.23e-06	0.000105	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—ABCB1—epilepsy syndrome	7.23e-06	0.000105	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—CCR5—epilepsy syndrome	7.13e-06	0.000104	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—GLUL—epilepsy syndrome	7.12e-06	0.000104	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—ADSL—epilepsy syndrome	7.08e-06	0.000103	CbGpPWpGaD
Telmisartan—ABCG2—Transmembrane transport of small molecules—ALB—epilepsy syndrome	7.04e-06	0.000103	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—ADRA2A—epilepsy syndrome	7.03e-06	0.000102	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—BCHE—epilepsy syndrome	7e-06	0.000102	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—CACNA1D—epilepsy syndrome	6.99e-06	0.000102	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—HTR2A—epilepsy syndrome	6.97e-06	0.000102	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—GLUL—epilepsy syndrome	6.95e-06	0.000101	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—AGT—epilepsy syndrome	6.91e-06	0.000101	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—CACNA1D—epilepsy syndrome	6.82e-06	9.94e-05	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—epilepsy syndrome	6.78e-06	9.89e-05	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—APOE—epilepsy syndrome	6.77e-06	9.87e-05	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—GPX1—epilepsy syndrome	6.72e-06	9.8e-05	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—TNF—epilepsy syndrome	6.71e-06	9.79e-05	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—SLC2A1—epilepsy syndrome	6.67e-06	9.73e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—TSC2—epilepsy syndrome	6.63e-06	9.66e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—AGT—epilepsy syndrome	6.62e-06	9.65e-05	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—epilepsy syndrome	6.6e-06	9.63e-05	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—PLCB1—epilepsy syndrome	6.6e-06	9.63e-05	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—TH—epilepsy syndrome	6.58e-06	9.59e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—TXNRD1—epilepsy syndrome	6.54e-06	9.53e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—APOE—epilepsy syndrome	6.48e-06	9.45e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—TXNRD1—epilepsy syndrome	6.38e-06	9.3e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—KDR—epilepsy syndrome	6.35e-06	9.26e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—AQP1—epilepsy syndrome	6.34e-06	9.25e-05	CbGpPWpGaD
Telmisartan—ABCB1—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	6.34e-06	9.24e-05	CbGpPWpGaD
Telmisartan—ABCB1—Transmembrane transport of small molecules—AVP—epilepsy syndrome	6.28e-06	9.16e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—AQP1—epilepsy syndrome	6.19e-06	9.03e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—PRKCB—epilepsy syndrome	6.11e-06	8.92e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	6.09e-06	8.88e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—IL6ST—epilepsy syndrome	6.09e-06	8.88e-05	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—AGT—epilepsy syndrome	5.89e-06	8.59e-05	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—POMC—epilepsy syndrome	5.81e-06	8.47e-05	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—APOE—epilepsy syndrome	5.77e-06	8.42e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—CHRM3—epilepsy syndrome	5.74e-06	8.37e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—KCNJ11—epilepsy syndrome	5.74e-06	8.37e-05	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—epilepsy syndrome	5.66e-06	8.25e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—CHRM3—epilepsy syndrome	5.6e-06	8.17e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—KCNJ11—epilepsy syndrome	5.6e-06	8.17e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—POMC—epilepsy syndrome	5.57e-06	8.12e-05	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—HMOX1—epilepsy syndrome	5.49e-06	8.01e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—CCL2—epilepsy syndrome	5.45e-06	7.95e-05	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—CAT—epilepsy syndrome	5.42e-06	7.9e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	5.34e-06	7.79e-05	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—ALB—epilepsy syndrome	5.3e-06	7.73e-05	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—ABCB1—epilepsy syndrome	5.27e-06	7.68e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	5.24e-06	7.63e-05	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—AKT1—epilepsy syndrome	5e-06	7.29e-05	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—POMC—epilepsy syndrome	4.96e-06	7.23e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—FGF2—epilepsy syndrome	4.93e-06	7.18e-05	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—GPX1—epilepsy syndrome	4.9e-06	7.14e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—ABCG2—epilepsy syndrome	4.68e-06	6.82e-05	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—PTGS2—epilepsy syndrome	4.64e-06	6.76e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—RELA—epilepsy syndrome	4.57e-06	6.67e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—ABCG2—epilepsy syndrome	4.57e-06	6.66e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—CYP11A1—epilepsy syndrome	4.53e-06	6.61e-05	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—ALB—epilepsy syndrome	4.52e-06	6.59e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	4.5e-06	6.56e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—MTOR—epilepsy syndrome	4.48e-06	6.54e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—CYP2C19—epilepsy syndrome	4.45e-06	6.49e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—CYP11A1—epilepsy syndrome	4.42e-06	6.45e-05	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—AGT—epilepsy syndrome	4.3e-06	6.26e-05	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—epilepsy syndrome	4.21e-06	6.14e-05	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—APOE—epilepsy syndrome	4.21e-06	6.14e-05	CbGpPWpGaD
Telmisartan—AGTR1—GPCR downstream signaling—AKT1—epilepsy syndrome	4.16e-06	6.07e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—CASP3—epilepsy syndrome	4.12e-06	6.01e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	4.1e-06	5.98e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—CYP2D6—epilepsy syndrome	4.09e-06	5.96e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—JUN—epilepsy syndrome	4.01e-06	5.84e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—CYP2D6—epilepsy syndrome	3.99e-06	5.82e-05	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—PTGS2—epilepsy syndrome	3.96e-06	5.77e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—MMP9—epilepsy syndrome	3.9e-06	5.68e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—ADRA2A—epilepsy syndrome	3.89e-06	5.67e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—BCHE—epilepsy syndrome	3.88e-06	5.65e-05	CbGpPWpGaD
Telmisartan—ABCB1—Transmembrane transport of small molecules—ALB—epilepsy syndrome	3.81e-06	5.55e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—ADRA2A—epilepsy syndrome	3.8e-06	5.54e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—BCHE—epilepsy syndrome	3.78e-06	5.52e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—AKT1—epilepsy syndrome	3.78e-06	5.51e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—SLC2A1—epilepsy syndrome	3.7e-06	5.39e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—PLCB1—epilepsy syndrome	3.66e-06	5.33e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—TH—epilepsy syndrome	3.64e-06	5.31e-05	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—POMC—epilepsy syndrome	3.62e-06	5.27e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—SLC2A1—epilepsy syndrome	3.61e-06	5.26e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—SRC—epilepsy syndrome	3.59e-06	5.24e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	3.59e-06	5.23e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—PLCB1—epilepsy syndrome	3.57e-06	5.2e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—TH—epilepsy syndrome	3.56e-06	5.19e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—VEGFA—epilepsy syndrome	3.5e-06	5.1e-05	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—ALB—epilepsy syndrome	3.3e-06	4.81e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—HMOX1—epilepsy syndrome	3.04e-06	4.43e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—CAT—epilepsy syndrome	3e-06	4.38e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—HMOX1—epilepsy syndrome	2.97e-06	4.33e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—CAT—epilepsy syndrome	2.93e-06	4.27e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—ABCB1—epilepsy syndrome	2.92e-06	4.26e-05	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—PTGS2—epilepsy syndrome	2.88e-06	4.21e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—GPX1—epilepsy syndrome	2.71e-06	3.96e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—GPX1—epilepsy syndrome	2.65e-06	3.86e-05	CbGpPWpGaD
Telmisartan—PPARG—Gene Expression—AKT1—epilepsy syndrome	2.56e-06	3.73e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—AGT—epilepsy syndrome	2.38e-06	3.47e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—APOE—epilepsy syndrome	2.33e-06	3.4e-05	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—AKT1—epilepsy syndrome	2.33e-06	3.4e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—AGT—epilepsy syndrome	2.32e-06	3.39e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—APOE—epilepsy syndrome	2.28e-06	3.32e-05	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—AKT1—epilepsy syndrome	2.23e-06	3.26e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—POMC—epilepsy syndrome	2e-06	2.92e-05	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—AKT1—epilepsy syndrome	1.99e-06	2.9e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—POMC—epilepsy syndrome	1.95e-06	2.85e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—ALB—epilepsy syndrome	1.83e-06	2.66e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—ALB—epilepsy syndrome	1.78e-06	2.6e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—PTGS2—epilepsy syndrome	1.6e-06	2.33e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—PTGS2—epilepsy syndrome	1.56e-06	2.27e-05	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—AKT1—epilepsy syndrome	1.45e-06	2.11e-05	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—AKT1—epilepsy syndrome	8.03e-07	1.17e-05	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—AKT1—epilepsy syndrome	7.84e-07	1.14e-05	CbGpPWpGaD
